F6E-33369-03323
4 vaccinations
1 coded response
27 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 948 / CA
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Registered in v-safe
- 2021-01-28
- 2021-02-02
-
2021-02-09
Dose 2 — Pfizer-BioNTech
-
2021-02-09
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to workAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-18
- 2021-03-25
- 2021-05-11
- 2021-08-10
-
2021-11-22
Dose 3 — Pfizer-BioNTech
- 2022-02-11
- 2022-02-21
- 2022-05-23
-
2022-11-03
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-22
Survey response — 12 months, dose 3MedDRA: Delivery, Pregnancy — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Had a baby with preeclampsia · Healthcare visit (other): Stay in antepartumMedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
-
2022-11-23
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-24
- 2022-12-01
- 2022-12-08
- 2022-12-15
- 2023-02-02
- 2023-05-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech | |
| 3 | 2021-11-22 | Pfizer-BioNTech | No |
| 4 | 2022-11-03 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
Free text
Release 12 — 12 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Pregnancy | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release